Long-term functional outcome after hyperthermic isolated limb perfusion (HILP)

International Journal of Hyperthermia

Volumn 24, Issue 5, 2008, Pages 409-414

  Knorr, Christian ^a   Melling, N ^a   Goehl, J ^a   Drachsler, T ^a   Hohenberger, W ^a   Meyer, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Follow up; Limb perfusion; Long term complications; Malignant melanoma

Indexed keywords

ADULT; AGED; ARM; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPRESSION GARMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; ELBOW; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; LEG; LIMB PERFUSION; LIMB SWELLING; LONG TERM CARE; LYMPHATIC DRAINAGE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; NEUROLOGIC DISEASE; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RANGE OF MOTION; RISK ASSESSMENT; SHOULDER; SOCIAL LIFE; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ARM; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; LEG; LYMPHEDEMA; MALE; MELANOMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RANGE OF MOTION, ARTICULAR;

EID: 50849095752     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730801975249     Document Type: Article

References (13)

1. Creech Jr, OJ, Krementz, ET, Ryan, RF and Winbald, JN (1958) Chemtherapy of cancer: Regional perfusion utilizing an extracorporal circuit. Ann Surg, 148, pp. 616-632.
2. Di Filippo, F, Cavaliere, F. Garinei, R. et al. (2004) TNFα-based isolated hyperthermic limb perfusion (HILP) in the treatment of limb recurrent melanoma: Update 16 years after its first clinical application. J Chemother, 16, pp. 62-65.
3. Hohenberger, W. (1990) Isolation perfusion for malignant melanomas: Established facts and parameters to be clarified. Progress in regional cancer therapy, p. 182. Springer, Berlin, Heidelberg, New York
4. Knorr, C., Meyer, T., Janssen, T., Goehl, J. and Hohenberger, W. (2006) Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients. Eur J Surg Oncol, 32:2, pp. 224-227.
5. Meyer, T., Gohl, J., Haas, C. and Hohenberger, W. (1998) Hyperthermic isolated limb perfusion-23 years' experience and improvement of results by modification of technique. Onkologie, 21, pp. 198-202.
6. Tonak, J., Hohenberger, W. and Gohl, J. (1984) Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas. Chirurg, 55:8, pp. 499-504.
7. Van Geel, AN, van Wijk, J. and Wieberdink, J. (1989) Functional morbidity after regional isolated perfusion of the limb for melanoma. Cancer, 63:6, pp. 1092-1096.
8. Vrouenrates, BC, Eggermont, AM Klaase, JM et al. (1994) Long-term neuropathy after regional isolated pefusion with meplhalan for melanoma of the limbs. Eur J Surg Oncol, 20:6, pp. 681-685.
9. Vrouenrates, BC, in't Veld, GJ Nieweg, OE et al. (1999) Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan. Eur J Surg Oncol, 25:5, pp. 503-508.
10. Meyer, T., Merkel, S., Gohl, J. and Hohenberger, W. (2002) Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol, 28, pp. 424-430.
11. Olieman, AF Koops, HS et al. (1994) Functional morbidity of hyperthermic isolated regional perfusion of the extremities. Ann Surg Oncol, 1:5, pp. 382-388.
12. Koops, HS, Vaglini, M. Suciu, S. et al. (1998) Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol, 16, pp. 2906-2912.
13. Kapma, MR, Vrouenrates, BC Nieweg, OE et al. (2005) Major amputation for intractable extremity melanoma after failure of isolated limb perfusion. Eur J Surg Oncol, 31:1, pp. 95-99.